Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been given an average rating of “Hold” by the sixteen analysts that are covering the company, MarketBeat.com reports. Three analysts have rated the stock with a sell recommendation, three have given a hold recommendation and ten have issued a buy recommendation on the company. The average 12 month target price among brokerages that have issued ratings on the stock in the last year is $583.17.

ISRG has been the subject of a number of research analyst reports. Cantor Fitzgerald set a $620.00 price target on Intuitive Surgical and gave the company a “buy” rating in a report on Friday, July 19th. Zacks Investment Research downgraded Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Wednesday, April 24th. Canaccord Genuity reaffirmed a “buy” rating and issued a $610.00 price target (up from $575.00) on shares of Intuitive Surgical in a report on Friday, July 19th. BTIG Research reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Sunday, April 21st. Finally, ValuEngine downgraded Intuitive Surgical from a “hold” rating to a “sell” rating in a report on Friday, July 12th.

ISRG traded down $14.71 on Wednesday, reaching $503.29. The company’s stock had a trading volume of 414,717 shares, compared to its average volume of 735,843. The business has a 50 day simple moving average of $524.60. The company has a market capitalization of $58.01 billion, a P/E ratio of 53.03, a price-to-earnings-growth ratio of 3.83 and a beta of 1.12. Intuitive Surgical has a fifty-two week low of $430.24 and a fifty-two week high of $589.32.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $3.25 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.23 by $1.02. The firm had revenue of $1.10 billion during the quarter, compared to the consensus estimate of $1.03 billion. Intuitive Surgical had a return on equity of 17.35% and a net margin of 29.95%. The firm’s quarterly revenue was up 20.9% compared to the same quarter last year. During the same period in the prior year, the company posted $2.76 earnings per share. As a group, equities analysts predict that Intuitive Surgical will post 10.15 earnings per share for the current fiscal year.

In other news, VP Jamie Samath sold 130 shares of the stock in a transaction that occurred on Monday, June 10th. The stock was sold at an average price of $500.60, for a total value of $65,078.00. Following the completion of the sale, the vice president now directly owns 219 shares of the company’s stock, valued at $109,631.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, VP Marshall Mohr sold 15,000 shares of the stock in a transaction that occurred on Monday, July 29th. The shares were sold at an average price of $526.11, for a total value of $7,891,650.00. Following the completion of the sale, the vice president now directly owns 20,135 shares of the company’s stock, valued at $10,593,224.85. The disclosure for this sale can be found here. Insiders sold 25,882 shares of company stock valued at $13,664,919 over the last three months. Corporate insiders own 1.70% of the company’s stock.

Several hedge funds have recently bought and sold shares of ISRG. Dimensional Fund Advisors LP raised its position in shares of Intuitive Surgical by 2.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 192,383 shares of the medical equipment provider’s stock valued at $92,131,000 after buying an additional 4,175 shares in the last quarter. Nordea Investment Management AB raised its position in Intuitive Surgical by 4.8% in the 4th quarter. Nordea Investment Management AB now owns 6,569 shares of the medical equipment provider’s stock worth $3,146,000 after purchasing an additional 300 shares during the period. Washington Trust Bank raised its position in Intuitive Surgical by 192.3% in the 1st quarter. Washington Trust Bank now owns 114 shares of the medical equipment provider’s stock worth $65,000 after purchasing an additional 75 shares during the period. Huntington National Bank raised its position in Intuitive Surgical by 40.1% in the 1st quarter. Huntington National Bank now owns 5,147 shares of the medical equipment provider’s stock worth $2,936,000 after purchasing an additional 1,472 shares during the period. Finally, We Are One Seven LLC raised its position in Intuitive Surgical by 322.6% in the 1st quarter. We Are One Seven LLC now owns 1,086 shares of the medical equipment provider’s stock worth $619,000 after purchasing an additional 829 shares during the period. 86.09% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

See Also: After-Hours Trading

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.